Urticarial Vasculitis After First Denosumab Injection in an Osteoporotic Woman Diagnosed with Cushing’s Syndrome
Denosumab is a human-derived monoclonal immunoglobulin G2 antibody against the receptor activator of nuclear factor kappa B ligand, inhibiting the differentiation and function of osteoclast precursor cells by its antiosteoclastic action. Denosumab is approved for postmenopausal, glucocorti coid-indu...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Society of Endocrinology and Metabolism of Turkey
2022-09-01
|
| Series: | Endocrinology Research and Practice |
| Subjects: | |
| Online Access: | https://endocrinolrespract.org/index.php/pub/article/view/1123 |
| Tags: |
No Tags, Be the first to tag this record!
|